AVENIO ctDNA Surveillance Kit Clinical Trials
2 recruitingDevice
Phase 21Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 3
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
Non-small Cell Lung CancerNSCLCNSCLC Stage III
Maximilian Diehn48 enrolled1 locationNCT04585490
Recruiting
Phase 2
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
Non-small Cell Lung CancerNon-Small Cell Lung Cancer (Stage III)Non-small Cell Lung Cancer Stage I+1 more
Stanford University80 enrolled1 locationNCT04585477